Equities research analysts at StockNews.com began coverage on shares of Seagen (NASDAQ:SGEN – Get Free Report) in a research report issued to clients and investors on Wednesday. The brokerage set a “hold” rating on the biotechnology company’s stock. Other equities research analysts also recently issued reports about the stock. Morgan Stanley reaffirmed an “equal weight” […]
Shares of Seagen Inc. (NASDAQ:SGEN – Get Free Report) have received a consensus recommendation of “Hold” from the seventeen analysts that are currently covering the firm, Marketbeat Ratings reports. Eleven analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The average 12-month price objective among […]
Seagen (NASDAQ:SGEN – Get Free Report)‘s stock had its “hold” rating reiterated by analysts at Truist Financial in a note issued to investors on Wednesday, Benzinga reports. They currently have a $229.00 price target on the biotechnology company’s stock. Truist Financial’s price target would indicate a potential upside of 6.40% from the company’s previous close. […]
StockNews.com initiated coverage on shares of Seagen (NASDAQ:SGEN – Free Report) in a report released on Tuesday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Other equities research analysts have also issued research reports about the stock. Truist Financial reaffirmed a hold rating and set a $229.00 target price on shares […]
Institute for Wealth Management LLC. decreased its position in Seagen Inc. (NASDAQ:SGEN – Free Report) by 2.1% during the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 2,980 shares of the biotechnology company’s stock after selling 63 shares during the period. Institute for Wealth Management LLC.’s holdings in Seagen […]